Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B

Grade Last Price % Change $ Change
grade A $190.75 0.00% 0.0
BIO.B closed unchanged on Thursday, February 23, 2017, on 1 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical BIO.B trend table...

Date Alert Name Type % Chg
Feb 23 Narrow Range Bar Range Contraction 0.00%
Feb 23 Upper Bollinger Band Walk Other 0.00%
Feb 23 Reversal New Highs Setup Bullish Swing Setup 0.00%
Feb 23 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Feb 21 Narrow Range Bar Range Contraction 0.00%
Feb 21 Calm After Storm Range Contraction 0.00%
Feb 17 Narrow Range Bar Range Contraction 0.00%
Feb 17 New Uptrend Bullish 0.00%
Feb 17 Calm After Storm Range Contraction 0.00%
Feb 16 New 52 Week High Bullish 0.00%

Older signals for BIO.B ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Profile
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 190.75
52 Week Low 124.5
Average Volume 143
200-Day Moving Average 159.7
50-Day Moving Average 184.68
20-Day Moving Average 188.35
10-Day Moving Average 189.27
Average True Range 0.41
ADX 29.24
+DI 80.68
-DI: 28.62
Chandelier Exit (Long, 3 ATRs) 189.52
Chandelier Exit (Short, 3 ATRs) 188.38
Upper Bollinger Band 191.03
Lower Bollinger Band 185.67
Percent B (%b) 0.95
Bandwidth 0.028458